Composition comprising phosphatidyl serine and an antigen or allergen and the use thereof
US8765721B2 · kind B2 · utility
0Cited by
2References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 2, 2005 |
| Grant date | Jul 1, 2014 |
| Priority date | — |
| Expiry date | Sep 16, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/55511
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is a composition comprising a phosphatidyl serine receptor ligand for use in immune therapy. The composition may include an antigen or allergen together with the phosphatidyl serine receptor ligand. The compositions may be used for any type of immune therapy, such as immune modulation to an environmental antigen or allergen, down regulation of immune hypersensitivity reactions, and stimulation of antigen or allergen specific IgA and/or IgG4.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.